Andrea Anderson

Investigators saw relationships between germline epitope burdens in frequently amplified driver genes and immunoediting-related breast cancer features.

Researchers combined tumor sequence, transcriptome, and patient immune cell response clues in their tumor-specific neoantigen detection and validation platform.

A collection of papers has provided a look at findings from the All of Us Research Program's release of 245,388 clinical-grade genome sequences.

Researchers used circulating tumor DNA to characterize subtypes of classic Hodgkin lymphoma, treatment responses, and residual disease markers portending potential relapse.

Researchers developed an early ovarian cancer test based on DNA from Pap smears from women who went on to develop high-grade serous ovarian cancer.

Researchers tracked down a handful of previously unappreciated susceptibility genes using exome sequences for more than 244,000 European women with or without breast cancer.

Using data from bone marrow registry participants, researchers found an HLA variant linked to symptom-free SARS-CoV-2 infection and better immune cell responses.

Members of the DDD study team diagnosed more than 5,500 children with rare diseases from the UK and Ireland using exome sequencing and microarrays.

Sequencing on gastric cancer cases and controls helped flag nine susceptibility genes, including genes that interact with Helicobacter pylori infection to bump up risk.

Features found in the blood offered a more refined look at obesity and related conditions, shifting more readily than body mass index in response to lifestyle changes.